YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Ajanta Pharma
Ajanta Pharma
BSE: 532331NSE: AJANTPHARMISIN: INE031B01049

21st-Apr-2021 14:29Source: BSE

Ajanta Pharma - Board Meeting Intimation for Considering And Approving Results

AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Friday, 30th April 2021 to inter-alia consider and approve:

a. Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2021; and
b. Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2021.

You are requested to please take note of the same and disseminate to all concerned.

Sections